Search filters

Filters
Clear All

Phase

  • 182
  • 151
  • 2
  • 188
  • 147
  • 17
  • 373
  • 1196
  • 568
  • 28
  • 44
  • 2
  • 1128
  • 1197
  • 5

Found 1202 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

 Study of Immune Checkpoint Inhibition with Chemotherapy in Treatment-Na ve Metastatic Anal Cancer Patients
18 years - 99 years
All genders
Interventional
This trial compares the addition of nivolumab to chemotherapy (carboplatin and paclitaxel) versus usual treatment (chemotherapy alone) for the treatment of anal cancer that has spread to other places in the body (metastatic). Chemotherapy drugs, such as carboplatin and paclitaxel, work in different ways to stop the growth of tumor …
40 years - 99 years
All genders
Interventional
The purpose of this study is to test letermovir when given to people who have both well-controlled HIV infection and asymptomatic CMV infection. This study will also gather data on the effectiveness of letermovir to reduce inflammation when compared to no anti-CMV study treatment. In addition, the study will collect …
 A Phase 1/2a Study to Evaluate the Safety, Tolerability, Immunogenicity, andAnti-Tumor Activity of GEN-009 Adjuvanted Vaccine in Adult Patients with Selected SolidTumors
18 years - 99 years
All genders
To evaluate an investigational, personalized adjuvanted vaccine, GEN-009, that is being developed for the treatment of patients with solid tumors. A personalized vaccine, consisting of between 4 to 20 synthetic long peptides, will be generated for each patient and shall be administered as an adjuvanted vaccine, with the adjuvant Hiltonol.
18 years - 99 years
All genders
Interventional
This is an extension study for subjects over the age of 18, diagnosed with moderate-to-severe atopic dermatitis and enrolled in our main study IRB # 845325. This research study is being conducted to test the safety of lebrikizumab and potential side effects. Procedures include Physical exams, Medical History, blood and …
 An Open-Label Study For Continued Treatment Access For Participants From The B9991032 Avelumab Study
18 years - 99 years
All genders
Phase 2
The purpose of the continuation sub-study is to provide continued treatment access for participants from the B9991032 Parent Study who are deriving benefit from study treatment as judged by the investigator.
18 years - 99 years
All genders
The purpose of this study is to assess the safety of ALM-488, and to learn how well it shows nerve tissue in the body.
99 years or below
All genders
Interventional
The purpose of this extension trial is to find out how safe and how well the trial drug, apraglutide, is tolerated when you are treated for up to 104 weeks and to see if there are any changes in how much parenteral support (PS) you need.
12 years - 99 years
All genders
Interventional
The purpose of this study is to provide study drug APT-1011 to patients with Eosinophilic Esophagitis who have no suitable approved standard therapies for treatment and who are not eligible for other clinical trials. In addition, this program will collect tolerability, safety, and efficacy information.
18 years - 75 years
All genders
Interventional
The purpose of this study is to provide information about the safety and long-term effectiveness of the BWI irreversible electroporation (IRE) ablation system consisting of the TRUPULSE™ Generator and VARIPULSE™ Catheter. The Biosense Webster Inc. (BWI) IRE Ablation system is being studied for use in the treatment of Paroxysmal Atrial …
18 years - 99 years
All genders
Phase 2
Interventional
The purpose of this study are to determine the maximum dose of FF-10832 that can be tolerated when taken in combination with pembrolizumab and to determine whether FF10832 taken by itself or in combination with pembrolizumab has anti-tumor activity.
1041 - 1050 of 1202